Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19

Journal article

Open access

Peer reviewed

Ricardo Peña-Silva, Stephen B Duffull, Andrew C Steer, Sandra X Jaramillo-Rincon, Amanda Gwee and Xiao Zhu

British journal of clinical pharmacology, Vol.87(3), pp.1589-1590

03/2021

Handle:

https://hdl.handle.net/10523/36971

Abstract

Antiparasitic Agents - administration & dosage

Antiparasitic Agents - pharmacokinetics

Antiparasitic Agents - therapeutic use

Antiviral Agents - pharmacokinetics

COVID-19 - drug therapy

Drug Repositioning

Humans

Ivermectin - administration & dosage

Ivermectin - pharmacokinetics

Ivermectin - therapeutic use

SARS-CoV-2 - drug effects

Virus Replication - drug effects

url

https://doi.org/10.1111/bcp.14476View

Published (Version of record) Open

12 Record Views

Record Identifier: 9926529293201891
Title: Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19
Creators: Ricardo Peña-Silva
Stephen B Duffull
Andrew C Steer
Sandra X Jaramillo-Rincon
Amanda Gwee
Xiao Zhu
Publication Details: British journal of clinical pharmacology, Vol.87(3), pp.1589-1590
Academic Unit: School of Pharmacy
Grant note: Universidad de los Andes
Date published ; e-published: 03/2021
Language: English
Resource Type ; Subtype: Journal article